Knr and upcoming salesI have been thinking about the impact of the recent vaccine announcements and their impact on Knr. We have to remember that it will take a number of months before vaccines can be rolled out:
- they still require peer review and independent study though this could come fairly soon.
- the two vaccines announced will not be sufficient to vaccinate the population in Canada and the US let alone the world. More vaccines required.
- upon approval it will take many months to ramp up supply.
- distribution of vaccines will also take time.
- we don't know the period of efficacy for the vaccines (6 months? 1 year?)
My point is that businesses, schools, airlines (this is the very short list) along with the blue chip clientele that Knr already has should be clambering for BioCloud units as they roll off the production line. At $12 k per unit they are an inexpensive outlay of capital to keep businesses, etc. open as covid numbers skyrocket. There will be a demand for the product for months and perhaps even years to come.
I'm looking forward to the Fall Investor Summit and seeing Kontrol's presentation. Perhaps there will be news in the am but I'm not counting on it. That said, the timing for the presentation couldn't be better.